Skip to main content

Amantadine (International)

In the US, Amantadine (amantadine systemic) is a member of the following drug classes: adamantane antivirals, dopaminergic antiparkinsonism agents and is used to treat ADHD, Chronic Fatigue Syndrome, Extrapyramidal Reaction, Fatigue, Head Injury, Influenza, Influenza A, Influenza Prophylaxis, Parkinson's Disease, Post-Polio Syndrome, Sexual Dysfunction - SSRI Induced and Tardive Dyskinesia.

US matches:

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BB01

CAS registry number (Chemical Abstracts Service)

0000768-94-5

Chemical Formula

C10-H17-N

Molecular Weight

151

Therapeutic Categories

Antivirals for systemic use - Antiviral agent

Treatment of Parkinson's disease

Chemical Name

Tricyclo[3.3.1.1³,⁷]decan-1-amine

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs